News and Updates

Spotlight on Jessie Stover Jessie Stover is the Development Manager at Breakthrough T1D’s Indiana Chapter. Stover was born and raised in Evansville, Indiana, and she now lives in Indianapolis with her two cats, Milo and Zuko. She enjoys reading, crafting, concerts, and “baking gluten-free desserts so good that no one can tell they’re gluten-free.” Here, […]

Time in range is a metric measured by continuous glucose monitors. Learn about why it matters and future applications.

Breakthrough T1D is deeply saddened at the passing of William V. Tamborlane, M.D. Dr. Tamborlane was a tireless champion for the type 1 diabetes (T1D) community, a pioneering clinical scientist, dedicated physician, and longtime Breakthrough T1D partner, grantee, reviewer, advisor, and friend. “Bill Tamborlane was a giant in our field, and he will be terribly […]

Tandem’s Control-IQ+ is the first-ever automated insulin delivery system cleared in the U.S. for pregnancy with type 1 diabetes.

What is the pipeline? Every new medical device, therapy, treatment, and drug—including those for type 1 diabetes (T1D)—goes through the drug development pipeline. Getting a new therapy or device from the earliest stages of research eventually into the hands of people with T1D is a complicated process. Science takes time (from years to decades!), money […]

Analysis compiled by Avalere Health and supported by Breakthrough T1D (formerly JDRF) finds that research funded by the Special Diabetes Program (SDP) has yielded more than $50 billion in federal healthcare savings.  Created by Congress in 1997 and administered by the National Institutes of Health (NIH), the SDP provides federal funding to support research to prevent, treat, and […]

Moira McCarthy reflects on the transformative impact of automated insulin delivery systems, and how the T1D community made it possible.

Continuous glucose monitors have been transformative for daily type 1 diabetes management. Can they benefit people without diabetes?

Improving Lives Breakthrough T1D’s Improving Lives program focuses on devices, insulins, adjunctive therapies, treatments for complications, and psychosocial interventions to improve the health and quality of life of people living with T1D. Adjunctive therapies and complications There was significant focus on GLP-1 receptor agonists (GLP-1RAs) and SGLT inhibitors (SGLTi) in reducing long-term complications and improving […]

While we look back on 2024, we can reflect upon the incredible progress we’ve made in advancing breakthroughs toward cures and improving everyday life with T1D.   This wouldn’t have been possible without each and every one of you and your continued support of our mission as we drive toward cures for T1D.   Here are the […]